Many health-care companies and hospital industry groups are fighting a Trump administration policy tying extra federal coronavirus reimbursements to test results proving that patients are positive for Covid-19, saying the requirement unfairly deprives them of relief money established by Congress. Legislation in March provided hospitals a 20% boost to the standard federal Medicare reimbursement for each patient admitted for coronavirus.

Source: Wall Street Journal September 12, 2020 09:32 UTC